Clinical Trial Update: Gut Decolonisation With Neomycin/Metronidazole or Rifaximin Before Colon Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating gut decolonisation to prevent surgical site infections in colon surgery, comparing neomycin/metronidazole with rifaximin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Surgical Site Infection

Drugs mentioned

• Neomycin + Metronidazole (neomycin; metronidazole)
• Rifaximin (rifaximin)

Snippet

Sponsor: Universität Luzern | Conditions: Surgical Site Infection, Colon Surgery | Phase 4 | Status: NOT_YET_RECRUITING